NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $278,000 | – | 8,710 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,839,263 | $27,791,000 | 9.88% |
| Broadfin Capital, LLC | 1,696,754 | $25,638,000 | 5.02% |
| HARVEY CAPITAL MANAGEMENT INC | 1,057,800 | $15,982,000 | 4.96% |
| ArrowMark Colorado Holdings LLC | 578,750 | $8,745,000 | 2.35% |
| FCG ADVISORS, LLC | 140,805 | $2,128,000 | 1.73% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 600,471 | $9,073,000 | 1.54% |
| OAK RIDGE INVESTMENTS LLC | 2,782,714 | $42,047,000 | 1.32% |
| Lisanti Capital Growth, LLC | 139,340 | $2,510,000 | 1.20% |
| EMERALD ADVISERS, LLC | 1,193,198 | $18,029,000 | 1.10% |
| SECTORAL ASSET MANAGEMENT INC | 2,302,428 | $34,790,000 | 1.03% |